The gene mutations associated with advanced neoplasia in IPMN may be observed in MCN, including TP53, CDKN2A, SMAD4, and/or mTOR genes (PTEN, PIK3CA, AKT1) [9]. This evidence concerns the gene CDKN2A and pancreatic intraductal papillary-mucinous neoplasm.